Cargando…
Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial
BACKGROUND: Cardioembolism in paroxysmal atrial fibrillation (PAF) is a preventable cause of transient ischaemic attack (TIA) or ischaemic stroke; however, due to its transient nature, a short-duration Holter monitor may miss a significant proportion of events. METHODS: We conducted an open-label ra...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659210/ https://www.ncbi.nlm.nih.gov/pubmed/31349792 http://dx.doi.org/10.1186/s40001-019-0383-8 |
_version_ | 1783439088564568064 |
---|---|
author | Kaura, Amit Sztriha, Laszlo Chan, Fong Kum Aeron-Thomas, John Gall, Nicholas Piechowski-Jozwiak, Bartlomiej Teo, James T. |
author_facet | Kaura, Amit Sztriha, Laszlo Chan, Fong Kum Aeron-Thomas, John Gall, Nicholas Piechowski-Jozwiak, Bartlomiej Teo, James T. |
author_sort | Kaura, Amit |
collection | PubMed |
description | BACKGROUND: Cardioembolism in paroxysmal atrial fibrillation (PAF) is a preventable cause of transient ischaemic attack (TIA) or ischaemic stroke; however, due to its transient nature, a short-duration Holter monitor may miss a significant proportion of events. METHODS: We conducted an open-label randomised controlled trial of cardiac monitoring after a TIA or ischaemic stroke comparing a 14-day ECG monitoring patch (Zio(®) Patch, iRhythm Technologies) with short-duration Holter monitoring for the detection of PAF. The primary outcome was the detection of one or more episodes of ECG-documented PAF lasting at least 30 s within 90 days in each of the study arms. A budget impact analysis from the healthcare perspective was performed. RESULTS: From February 2016 through February 2017, 43 (76.8%) of the 56 patients assigned to the patch-based monitoring group and 47 (78.3%) of the 60 patients assigned to short-duration Holter monitoring group had successful monitor placement with 90 days of follow-up. Of the 26 protocol failures between the two groups, 23 (88.5%) were due to patient refusal for outpatient short-duration ECG monitor placement, whilst only 1 (3.8%) was due unsuccessful ZioPatch placement. The rate of detection of PAF at 90 days was 16.3% in the patch-based monitoring group (seven patients) compared to 2.1% in the short-duration Holter monitoring group (1 patient), with an odds ratio of 8.9 (95% CI 1.1–76.0; P = 0.026). An economic model demonstrated that implementation of the Zio Patch service would result in 10.8 more strokes avoided per year compared to current practice with Holter monitoring with an associated yearly saving in direct medical costs of £113,630, increasing to £162,491 over 5 years. CONCLUSIONS: Early, prolonged, patch-based monitoring after an index stroke or TIA is superior to short-duration Holter monitoring in the detection of PAF and likely cost-effective for preventing recurrent strokes. Trial registration http://www.isrctn.com. Unique identifier: ISRCTN 50253271. Registered 21 January 2016 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40001-019-0383-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6659210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66592102019-08-01 Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial Kaura, Amit Sztriha, Laszlo Chan, Fong Kum Aeron-Thomas, John Gall, Nicholas Piechowski-Jozwiak, Bartlomiej Teo, James T. Eur J Med Res Research BACKGROUND: Cardioembolism in paroxysmal atrial fibrillation (PAF) is a preventable cause of transient ischaemic attack (TIA) or ischaemic stroke; however, due to its transient nature, a short-duration Holter monitor may miss a significant proportion of events. METHODS: We conducted an open-label randomised controlled trial of cardiac monitoring after a TIA or ischaemic stroke comparing a 14-day ECG monitoring patch (Zio(®) Patch, iRhythm Technologies) with short-duration Holter monitoring for the detection of PAF. The primary outcome was the detection of one or more episodes of ECG-documented PAF lasting at least 30 s within 90 days in each of the study arms. A budget impact analysis from the healthcare perspective was performed. RESULTS: From February 2016 through February 2017, 43 (76.8%) of the 56 patients assigned to the patch-based monitoring group and 47 (78.3%) of the 60 patients assigned to short-duration Holter monitoring group had successful monitor placement with 90 days of follow-up. Of the 26 protocol failures between the two groups, 23 (88.5%) were due to patient refusal for outpatient short-duration ECG monitor placement, whilst only 1 (3.8%) was due unsuccessful ZioPatch placement. The rate of detection of PAF at 90 days was 16.3% in the patch-based monitoring group (seven patients) compared to 2.1% in the short-duration Holter monitoring group (1 patient), with an odds ratio of 8.9 (95% CI 1.1–76.0; P = 0.026). An economic model demonstrated that implementation of the Zio Patch service would result in 10.8 more strokes avoided per year compared to current practice with Holter monitoring with an associated yearly saving in direct medical costs of £113,630, increasing to £162,491 over 5 years. CONCLUSIONS: Early, prolonged, patch-based monitoring after an index stroke or TIA is superior to short-duration Holter monitoring in the detection of PAF and likely cost-effective for preventing recurrent strokes. Trial registration http://www.isrctn.com. Unique identifier: ISRCTN 50253271. Registered 21 January 2016 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40001-019-0383-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-26 /pmc/articles/PMC6659210/ /pubmed/31349792 http://dx.doi.org/10.1186/s40001-019-0383-8 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Kaura, Amit Sztriha, Laszlo Chan, Fong Kum Aeron-Thomas, John Gall, Nicholas Piechowski-Jozwiak, Bartlomiej Teo, James T. Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial |
title | Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial |
title_full | Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial |
title_fullStr | Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial |
title_full_unstemmed | Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial |
title_short | Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial |
title_sort | early prolonged ambulatory cardiac monitoring in stroke (epacs): an open-label randomised controlled trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659210/ https://www.ncbi.nlm.nih.gov/pubmed/31349792 http://dx.doi.org/10.1186/s40001-019-0383-8 |
work_keys_str_mv | AT kauraamit earlyprolongedambulatorycardiacmonitoringinstrokeepacsanopenlabelrandomisedcontrolledtrial AT sztrihalaszlo earlyprolongedambulatorycardiacmonitoringinstrokeepacsanopenlabelrandomisedcontrolledtrial AT chanfongkum earlyprolongedambulatorycardiacmonitoringinstrokeepacsanopenlabelrandomisedcontrolledtrial AT aeronthomasjohn earlyprolongedambulatorycardiacmonitoringinstrokeepacsanopenlabelrandomisedcontrolledtrial AT gallnicholas earlyprolongedambulatorycardiacmonitoringinstrokeepacsanopenlabelrandomisedcontrolledtrial AT piechowskijozwiakbartlomiej earlyprolongedambulatorycardiacmonitoringinstrokeepacsanopenlabelrandomisedcontrolledtrial AT teojamest earlyprolongedambulatorycardiacmonitoringinstrokeepacsanopenlabelrandomisedcontrolledtrial |